Abstract
The corona virus disease-19 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, had health and economic results that profoundly affected communities worldwide. Investigating the seroprevalence of SARS-Cov-2 in blood donors is of a significant clinical and scientific value as it adds to knowledge about local herd immunity levels.To study the prevalence of SARS-Cov-2 infection among blood donors at a tertiary referral hospital in the north of Jordan.This is a prospective study that included all blood donors between September 2020 and March 2021. Donors’ IgG antibodies were qualitatively immunoassayed to determine the antibody status against SARS-CoV-2. The Elecsys Anti-SARS-CoV-2 technique was utilized.One thousand samples were tested by total antibody against SARS-CoV-2. The median age was 29 years, 96.7% were males. The seroprevalence was 14.5%, and 80% of the positive participants did not report previous COVID-19 infection. The seroprevalence of COVID-19 antibodies was less among smokers and those with an O blood group and higher among donors with an AB blood group.The prevalence of COVID-19 among healthy young blood donors at a tertiary teaching health facility in the north of Jordan was 14.5%. Smokers and those with an O blood group were less likely to be seropositive, as opposed to donors with an AB blood group.
【초록키워드】 COVID-19, SARS-CoV-2, coronavirus, pandemic, Immunity, antibody, knowledge, Prospective Study, Infection, Local, virus, Prevalence, Health, IgG antibody, COVID-19 infection, Community, COVID-19 antibody, Jordan, seropositive, Blood, Blood Group, Donor, blood donor, smoker, acute respiratory syndrome, median age, participant, positive, antibody status, males, tertiary referral hospital, tested, affected, caused, healthy, less, determine, Elecsy, prevalence of COVID-19, 【제목키워드】 COVID-19, technology, Jordan, university, Blood, Science,